K Gwinn-Hardy Selected Research

K Gwinn-Hardy Research Topics

8	Parkinson Disease (Parkinson's Disease) 03/2007 - 06/2000
6	Parkinsonian Disorders (Parkinsonism) 11/2001 - 06/2000
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 04/2005 - 09/2000
2	Tremor (Tremors) 03/2004 - 10/2000
2	Dementia (Dementias) 11/2001 - 06/2000
1	Paroxysmal nonkinesigenic dyskinesia 05/2007
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2005
1	Unconsciousness (Loss of Consciousness) 12/2004
1	Pain (Aches) 12/2004
1	Lewy Body Disease (Lewy Body Dementia) 08/2004
1	Ataxia (Dyssynergia) 03/2004
1	Hypokinesia (Bradykinesia) 03/2004
1	Huntington Disease (Huntington's Disease) 01/2004
1	Frontotemporal Dementia (Semantic Dementia) 08/2000
1	Corticobasal Degeneration 08/2000
1	Alzheimer Disease (Alzheimer's Disease) 08/2000
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2000
1	Pick Disease of the Brain (Pick's Disease) 08/2000
1	Type 1 Familial Parkinson Disease 06/2000
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2000
1	Fatigue 03/2000
1	Restless Legs Syndrome (Restless Legs) 03/2000

4	alpha-SynucleinIBA 08/2004 - 06/2000
2	Levodopa (L Dopa)FDA LinkGeneric 03/2004 - 02/2001
2	DNA (Deoxyribonucleic Acid)IBA 03/2004 - 01/2004
1	Caffeine (No Doz)FDA LinkGeneric 05/2007
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2007
1	polyglutamineIBA 04/2005
1	tributyl phosphate (TBP)IBA 04/2005
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 04/2005
1	Biomarkers (Surrogate Marker)IBA 01/2005
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2004
1	Retinal Pigments (Pigments, Visual)IBA 11/2001
1	parkin proteinIBA 09/2001
1	Therapeutic UsesIBA 10/2000
1	Dopamine (Intropin)FDA LinkGeneric 09/2000
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 09/2000
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2000
1	tau Proteins (tau Protein)IBA 08/2000
1	AntibodiesIBA 06/2000
1	Amantadine (Aman)FDA LinkGeneric 03/2000

1	Splints (Splint) 10/2000